GT Biopharma Reports First Quarter 2026 Financial Results

Go back to GT Biopharma Reports First Quarter 2026 Financial Results
(NASDAQ: GTBP) Delayed: 0.32 +0.02 (6.67%)
Previous Close $0.30    52 Week High
Open $0.30    52 Week Low
Day High $0.33    P/E N/A 
Day Low $0.30    EPS
Volume 570,909